Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy

Recruiting Phase 2 Interventional Study
Immune Thrombocytopenia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 50
Sex
Female
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
100 (estimated)
Sponsor
Peking University People's Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a prospective, randomized, open-label, multicenter clinical trial study to compare the efficacy and safety of prednisone plus IVIg to prednisone monotherapy in the treatment of immune thrombocytopenia (ITP) in pregnancy.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age 18-50 years old; 2. Meet the diagnostic criteria for immune thrombocytopenia; 3. Pregnant women with ITP without ITP-specific treatments during pregnancy; 4. Gestational weeks ≥12 weeks; 5. Platelet count \<30×10\^9/L, accompanied with or without bleeding symptoms. 6. Wil…
Contacts

Xiaohui Zhang, Professor

+8613522338836

zhangxh100@sina.com

CONTACT

Haixia Fu, MD

13581830157

fuhaixia_210@163.com

CONTACT